These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28856784)

  • 61. Assessing treatment outcomes in toenail onychomycosis clinical trials.
    Werschler WP; Bondar G; Armstrong D
    Am J Clin Dermatol; 2004; 5(3):145-52. PubMed ID: 15186193
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
    Elewski BE; Aly R; Baldwin SL; González Soto RF; Rich P; Weisfeld M; Wiltz H; Zane LT; Pollak R
    J Am Acad Dermatol; 2015 Jul; 73(1):62-9. PubMed ID: 25956661
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
    Tosti A; Piraccini BM; Stinchi C; Colombo MD
    Dermatology; 1998; 197(2):162-6. PubMed ID: 9732167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical inquiries. Which oral antifungal is best for toenail onychomycosis?
    Hinojosa JR; Hitchcock K; Rodriguez JE
    J Fam Pract; 2007 Jul; 56(7):581-2. PubMed ID: 17605954
    [No Abstract]   [Full Text] [Related]  

  • 66. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data.
    Epstein E
    Arch Dermatol; 1998 Dec; 134(12):1551-4. PubMed ID: 9875192
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
    Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
    J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Onychomycosis: strategies to improve efficacy and reduce recurrence.
    Gupta AK; Baran R; Summerbell R
    J Eur Acad Dermatol Venereol; 2002 Nov; 16(6):579-86. PubMed ID: 12482040
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term evaluation of terbinafine 250 and 500 mg daily in a 16-week oral treatment for toenail onychomycosis.
    De Cuyper C
    Br J Dermatol; 1996 Jul; 135(1):156-7. PubMed ID: 8776393
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical comparison and complete cure rates of Terbinafine efficacy in affected onychomycotic toenails.
    Shemer A; Sakka N; Baran R; Scher R; Amichai B; Norman L; Farhi R; Magun R; Brazilai A; Daniel R
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):521-6. PubMed ID: 25079781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
    J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Update in antifungal therapy of dermatophytosis.
    Gupta AK; Cooper EA
    Mycopathologia; 2008; 166(5-6):353-67. PubMed ID: 18478357
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
    Piraccini BM; Sisti A; Tosti A
    J Am Acad Dermatol; 2010 Mar; 62(3):411-4. PubMed ID: 20159308
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efinaconazole and Tavaborole.
    Poulakos M; Grace Y; Machin JD; Dorval E
    J Pharm Pract; 2017 Apr; 30(2):245-255. PubMed ID: 26873506
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies.
    Gupta AK; Hall S; Zane LT; Lipner SR; Rich P
    J Dermatolog Treat; 2018 Feb; 29(1):44-48. PubMed ID: 28521541
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome®) in patients with onychomycosis.
    Dominicus R; Weidner C; Tate H; Kroon HA
    Br J Dermatol; 2012 Jun; 166(6):1360-2. PubMed ID: 22136723
    [No Abstract]   [Full Text] [Related]  

  • 78. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study.
    Amichai B; Nitzan B; Mosckovitz R; Shemer A
    Br J Dermatol; 2010 Jan; 162(1):46-50. PubMed ID: 19785609
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution.
    Cantrell W; Canavan T; Elewski B
    J Drugs Dermatol; 2015 May; 14(5):524-6. PubMed ID: 25942674
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.